Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 9 articles: HTML format

Single Articles

May 2023
1. GU L, Zhu Y, Lee M, Nguyen A, et al
   Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
   Proc Natl Acad Sci U S A. 2023;120:e2300706120.
   PubMed     Abstract available
   
   
   
2. ZHANG J, Ning Y, Zhu H, Rotile NJ, et al
   Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T(1)-weighted MRI.
   Proc Natl Acad Sci U S A. 2023;120:e2220036120.
   PubMed     Abstract available
   
   
   January 2023
3. LUUKKONEN PK, Sakuma I, Gaspar RC, Mooring M, et al
   Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis.
   Proc Natl Acad Sci U S A. 2023;120:e2217543120.
   PubMed     Abstract available
   
   
   March 2022
4. KAPS L, Huppertsberg A, Choteschovsky N, Klefenz A, et al
   pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages.
   Proc Natl Acad Sci U S A. 2022;119:e2122310119.
   PubMed     Abstract available
   
   
   July 2021
5. NISHIO T, Koyama Y, Liu X, Rosenthal SB, et al
   Immunotherapy-based targeting of MSLN(+) activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   April 2021
6. NISHIMURA N, De Battista D, McGivern DR, Engle RE, et al
   Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   March 2021
7. PICCOLO P, Ferriero R, Barbato A, Attanasio S, et al
   Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   December 2020
8. YUEH MF, He F, Chen C, Vu C, et al
   Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease.
   Proc Natl Acad Sci U S A. 2020;117:31259-31266.
   PubMed     Abstract available
   
   
   November 2020
9. SCHIERWAGEN R, Dietrich P, Klein S, Uschner FE, et al
   beta-Arrestin2 is increased in liver fibrosis in humans and rodents.
   Proc Natl Acad Sci U S A. 2020;117:27082-27084.
   PubMed    
   
   

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.